Market research

For retail sale medicaments with penicillins or streptomycins market in Spain

For retail sale medicaments with penicillins or streptomycins market in Spain

Release date: Mar 29, 2026

Submission: 15 minutes after payment

Research period: 2017-2025

Report language:
English Русский

Submission method: to your account

File format: docx, xlsx

Single Report

$500
  • Instant access to detailed data on one specific market
  • Ideal for one-off tasks: niche assessments, presentations, investment decisions
  • Available in Excel and Word in 15 minutes after purchase
  • Cheaper than subscription, but each market requires a separate purchase
Best if you know exactly what you need

Platform Subscription

from$600
  • Complete and unlimited data access across products and regions
  • Includes continuous data updates during subscription period
  • Download reports instantly in Word, and Excel formats
  • More cost-effective for multiple markets or regular analysis
Ideal for regular data users

Earlier Report Observations

Between 2018 and 2021, the Spanish market for retail-packed medicaments containing penicillins or streptomycin derivatives remained within a narrow band of 83 to 87 million US dollars. Starting at 86.8 million in 2018, it stabilized at 86.3 million in 2019, dipped to 83.2 million in 2020, and recovered to 86.3 million by 2021.

In 2023, the market volume expanded significantly to 97.0 million US dollars, reaching its highest point in the period. This increase coincided with the commercialization of 43 new active substances in Spain, the highest number in a decade, which boosted pharmacological innovation and broadened the antibiotic supply following the COVID-19 pandemic. During the same year, the implementation of Royal Decree 666/2023 began, introducing stricter rules for the distribution and prescription of veterinary medicines with a focus on combating antimicrobial resistance.

The market contracted sharply to 59.2 million US dollars in 2024. This decline was influenced by the recall of a batch of amoxicillin capsules due to serious adverse reactions, which directly reduced available supply, alongside the continued tightening of regulations governing antibiotic use, including mandatory electronic reporting for veterinary prescriptions, which constrained consumption.

Table of content

  1. 1. Disclaimer
  2. 2. Terms of use of the report
  3. 3. Product codes in the statistical classifications used in the report
  4. 4. Key Market Indicators and Trends
    1. 4.1. Key Market Indicators
      1. 4.1.1. In value
        1. 4.1.1.1. Production, 2018-2021, 2023-2024
        2. 4.1.1.2. Imports, 2018-2024
        3. 4.1.1.3. Exports, 2018-2024
        4. 4.1.1.4. Market size, 2018-2021, 2023-2024
    2. 4.2. Market Trends and Factors
  5. 5. Production
    1. 5.1. Production in Spain
      1. 5.1.1. In value, 2018-2021, 2023-2024, M $ US
    2. 5.2. Production in the EU, 2018-2024
      1. 5.2.1. In value, 2018-2024, M $ US
  6. 6. Exports
    1. 6.1. Exports (Direct Data)
      1. 6.1.1. Exports - Total information
      2. 6.1.2. Exports in kind, t
        1. 6.1.2.1. Annual dynamics of product's exports from Spain in kind, 2018-2024, t
        2. 6.1.2.2. Dynamics of product's exports in kind from Spain by countries, 2018-2024, t
        3. 6.1.2.3. Structure of product's exports in kind by countries, 2018-2024
      3. 6.1.3. Exports in value, K $ US
        1. 6.1.3.1. Annual dynamics of product's exports from Spain in value, 2018-2024, K $ US
        2. 6.1.3.2. Dynamics of product's exports in value from Spain by countries, 2018-2024, K $ US
        3. 6.1.3.3. Structure of product's exports in value by countries, 2018-2024
      4. 6.1.4. Average price of product's exports, $ US/kg
        1. 6.1.4.1. Annual dynamics of average price of product's exports from Spain, 2018-2024, $ US/kg
        2. 6.1.4.2. Dynamics of average price of product's exports from Spain by countries, 2018-2024, $ US/kg
    2. 6.2. Exports (Mirror Data)
      1. 6.2.1. Exports - Total information
      2. 6.2.2. Exports in kind, t
        1. 6.2.2.1. Annual dynamics of product's exports from Spain in kind, 2018-2024, t
        2. 6.2.2.2. Dynamics of product's exports in kind from Spain by countries, 2018-2024, t
        3. 6.2.2.3. Structure of product's exports in kind by countries, 2018-2024
      3. 6.2.3. Exports in value, K $ US
        1. 6.2.3.1. Annual dynamics of product's exports from Spain in value, 2018-2024, K $ US
        2. 6.2.3.2. Dynamics of product's exports in value from Spain by countries, 2018-2024, K $ US
        3. 6.2.3.3. Structure of product's exports in value by countries, 2018-2024
      4. 6.2.4. Average price of product's exports, $ US/kg
        1. 6.2.4.1. Annual dynamics of average price of product's exports from Spain, 2018-2024, $ US/kg
        2. 6.2.4.2. Dynamics of average price of product's exports from Spain by countries, 2018-2024, $ US/kg
  7. 7. Imports
    1. 7.1. Imports (Direct Data)
      1. 7.1.1. Imports - Total information
      2. 7.1.2. Imports in kind, t
        1. 7.1.2.1. Annual dynamics of product's imports to Spain in kind, 2018-2024, t
        2. 7.1.2.2. Dynamics of product's imports in kind to Spain by countries, 2018-2024, t
        3. 7.1.2.3. Structure of product's imports in kind by countries, 2018-2024
      3. 7.1.3. Imports in value, K $ US
        1. 7.1.3.1. Annual dynamics of product's imports to Spain in value, 2018-2024, K $ US
        2. 7.1.3.2. Dynamics of product's imports in value to Spain by countries, 2018-2024, K $ US
        3. 7.1.3.3. Structure of product's imports in value by countries, 2018-2024
      4. 7.1.4. Average price of product's imports, $ US/kg
        1. 7.1.4.1. Annual dynamics of average price of product's imports to Spain, 2018-2024, $ US/kg
        2. 7.1.4.2. Dynamics of average price of product's imports to Spain by countries, 2018-2024, $ US/kg
    2. 7.2. Imports (Mirror Data)
      1. 7.2.1. Imports - Total information
      2. 7.2.2. Imports in kind, t
        1. 7.2.2.1. Annual dynamics of product's imports to Spain in kind, 2018-2024, t
        2. 7.2.2.2. Dynamics of product's imports in kind to Spain by countries, 2018-2024, t
        3. 7.2.2.3. Structure of product's imports in kind by countries, 2018-2024
      3. 7.2.3. Imports in value, K $ US
        1. 7.2.3.1. Annual dynamics of product's imports to Spain in value, 2018-2024, K $ US
        2. 7.2.3.2. Dynamics of product's imports in value to Spain by countries, 2018-2024, K $ US
        3. 7.2.3.3. Structure of product's imports in value by countries, 2018-2024
      4. 7.2.4. Average price of product's imports, $ US/kg
        1. 7.2.4.1. Annual dynamics of average price of product's imports to Spain, 2018-2024, $ US/kg
        2. 7.2.4.2. Dynamics of average price of product's imports to Spain by countries, 2018-2024, $ US/kg
  8. 8. Trade balance
    1. 8.1. Trade balance (Direct Data)
      1. 8.1.1. In kind, t
      2. 8.1.2. In value, K $ US
    2. 8.2. Trade balance (Mirror Data)
      1. 8.2.1. In kind, t
      2. 8.2.2. In value, K $ US
  9. 9. Top buying and selling countries, 2018-2024
    1. 9.1. Direct Data
      1. 9.1.1. Import in Value by Countries-buyers
      2. 9.1.2. Export in Value by Countries-suppliers
    2. 9.2. Mirror Data
      1. 9.2.1. Import in Value by Countries-buyers
      2. 9.2.2. Export in Value by Countries-suppliers

Production for retail sale medicaments with penicillins or streptomycins in Spain

In value, 2017-2020, M $ US

Spain's production of retail sale medicaments containing penicillins or streptomycins declined for the second consecutive year. In 2020, output was valued at 97.8 million US dollars, marking a 1.7% decrease compared to 2019. Looking at the broader period from 2017 to 2020, production actually grew by 30.5%, which translates to an average annual increase of 9.3%. The peak was reached in 2018, with production valued at 101.8 million US dollars. The most significant annual decline occurred in 2019, at 2.2%, while the largest increase was recorded in 2018, at 35.8%.

Annual dynamics of production in Spain in value, 2017-2020, M $ US

Parameter201820192020CAGR
1Change from last year35.8%(2.2%)(1.7%)9.3%
Source: SHEV.io

Exports for retail sale medicaments with penicillins or streptomycins from Spain

Exports in kind, t

Exports of retail sale medicaments containing penicillins or streptomycins from Spain declined for the third consecutive year. In 2020, exports totaled 5,164 tonnes, representing a 17.5% decrease compared to the previous year. Over the period from 2017 to 2020, exports fell by 41.2%, which corresponds to an average annual decline of 16.2%.

Annual dynamics of product's exports from Spain in kind, 2017-2020, t

Parameter201820192020CAGR
1Change from last year(5.0%)(25.0%)(17.5%)(16.2%)
Source: SHEV.io

From 2017 to 2020, France, Italy, and Belgium were the primary destinations for Spain's exports of these medicaments in volume terms. France accounted for 29.4% of exports, Italy for 17.3%, and Belgium for 11.2%. Together, these three countries represented 57.9% of total export volumes.

Structure of product's exports in kind by countries, 2017-2020

Source: SHEV.io

World map of product's exports from Spain in kind, 2017-2020

Source: SHEV.io

Exports in value, K $ US

In 2020, exports of retail sale medicaments containing penicillins or streptomycins from Spain were valued at 63,027 thousand US dollars, showing a 13.1% increase compared to the previous year. Over the period from 2017 to 2020, exports grew by 8.3%, with a compound annual growth rate of 2.7%. The lowest value was recorded in 2019, at 55,708 thousand US dollars, while the highest was in 2018, at 65,836 thousand US dollars. The most significant annual decline occurred in 2019, at 15.4%, and the largest increase was in 2018, at 13.1%.

Annual dynamics of product's exports from Spain in value, 2017-2020, K $ US

Parameter201820192020CAGR
1Change from last year13.1%(15.4%)13.1%2.7%
Source: SHEV.io

From 2017 to 2020, the value of exports for these medicaments from Spain was distributed across a wide range of markets. France was the largest destination, accounting for 18.0% of export value, followed by Portugal at 9.9% and the United Kingdom at 6.5%. Together, these three countries represented 34.4% of total export value, indicating a relatively diversified market structure.

Structure of product's exports in value by countries, 2017-2020

Source: SHEV.io

World map of product's exports from Spain in value, 2017-2020

Source: SHEV.io

Imports for retail sale medicaments with penicillins or streptomycins to Spain

Imports in kind, t

In 2020, imports of foreign retail sale medicaments containing penicillins or streptomycins into Spain totaled 3,151 tonnes, reflecting a significant increase of 14.2% compared to the previous year. Over the period from 2017 to 2020, imports grew by 6.2%, with a compound annual growth rate of 2.0%. The lowest volume was recorded in 2019, at 2,760 tonnes, which also saw the largest annual decline of 7.5%.

Annual dynamics of product's imports to Spain in kind, 2017-2020, t

Parameter201820192020CAGR
1Change from last year0.6%(7.5%)14.2%2.0%
Source: SHEV.io

From 2017 to 2020, Germany, Italy, and France were the main sources of imports for these medicaments into Spain in volume terms. Germany accounted for 47.0% of imports, Italy for 18.7%, and France for 17.4%. Combined, these three countries represented 83.1% of total import volumes.

Structure of product's imports in kind by countries, 2017-2020

Source: SHEV.io

World map of product's imports to Spain in kind, 2017-2020

Source: SHEV.io

Imports in value, K $ US

After two years of contraction, imports of retail sale medicaments containing penicillins or streptomycins into Spain increased in 2020. Imports were valued at 48,387 thousand US dollars, reflecting a 13.9% year-on-year rise. However, over the period from 2017 to 2020, imports decreased by 6.2%, which equates to an average annual decline of 2.1%. The lowest value was recorded in 2019, at 42,478 thousand US dollars, which also saw the largest annual decline of 16.3%.

Annual dynamics of product's imports to Spain in value, 2017-2020, K $ US

Parameter201820192020CAGR
1Change from last year(1.5%)(16.3%)13.9%(2.1%)
Source: SHEV.io

Throughout 2017 to 2020, France, Germany, and Austria formed the core group of markets for imports of these medicaments into Spain in value terms. France accounted for 38.4% of import value, Germany for 30.4%, and Austria for 10.1%. Together, these three countries represented 79.0% of total import value.

Structure of product's imports in value by countries, 2017-2020

Source: SHEV.io

World map of product's imports to Spain in value, 2017-2020

Source: SHEV.io

Why Choose Us?

Only Verified Data

We provide data exclusively verified by trusted sources and our proprietary validation algorithms.
Сompetitors offer unverified rough estimates, which can differ greatly from reality and therefore cannot be reliably used for decision-making

No Hidden Costs or Separate Fees

All critical data is included in our reports at no extra cost (e.g. top importers and exporters)
Competitors charge separately for essential sections, making their final reports significantly more expensive compared to ours

Smarter Subscription Pricing

Our subscription plans are among the best on the market, offering excellent value and flexibility
Competitors typically set significantly higher prices while offering fewer features and more limited data access

Contact Our Team

Submit your inquiry using the form below — our team will get back to you within 24 hours.

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. You can manage your preferences or learn more in our Privacy Policy.